Pharma Market Access Insights - from Petauri Evidence

podcast

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of ...

Business 74 recordings 2020 → today Monthly updated Apr 21
Search in Pharma Market Access Insights - from Petauri Evidence →

All episodes

1–20 of 74
Designing a Global Market Access Strategy Built for MFN contributed by Lukas · Apr 21
LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico contributed by Lukas · Apr 2
The Evolving NHS – An ICS Chief Pharmacist’s Perspective contributed by Lukas · Nov 17, 2025
First to Market: Unlocking Switzerland’s Pharma Potential contributed by Lukas · Nov 12, 2025
Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice contributed by Lukas · Oct 13, 2025
Global Pricing and Market Access – Strategies for Success in an Evolving Landscape contributed by Lukas · Jul 18, 2025
Transforming Global Market Access: Smarter Resource Management with Local Affiliates contributed by Lukas · Jun 3, 2025
Communicating value to US Payers: Insights for Pharma and Medtech contributed by Lukas · Apr 29, 2025
Navigating market access: Launch strategies and health economic modelling for medical devices contributed by Lukas · Apr 24, 2025
Navigating US payer evidence needs to optimise market access contributed by Lukas · Nov 27, 2024
Best practice RWE approaches to support economic modelling for HTA contributed by Lukas · Nov 20, 2024
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas contributed by Lukas · Nov 18, 2024
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology contributed by Lukas · Oct 11, 2024
NHS primary care panel – the GP Contract and Operational Planning Guidance contributed by Lukas · Sep 10, 2024
Engage NHS healthcare decision-makers with RWD contributed by Lukas · Aug 12, 2024
Market access and reimbursement in Canada – changes at CADTH contributed by Lukas · Jun 20, 2024
Rare Disease market access in the MENA and Nordic regions contributed by Lukas · May 10, 2024
How does funding flow in NHSE Regions? contributed by Lukas · Apr 9, 2024
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024) contributed by Lukas · Apr 9, 2024
De-mystifying health economic model classifications and structures contributed by Lukas · Mar 22, 2024
page 1 of 4 Next → »»

Charts

module · podcast

🇮🇪 #59 · 🇮🇳 #75 · 🇪🇸 #84 · 🇨🇭 #94 · 🇦🇷 #142 · 🇬🇧 #186 · +12 more

charted in 19 countriesFull rankings →

Activity

module · podcast

0 episodes · last 30 days

Mon 2Tue 1Wed 1

Episodes per week over the last six months.

About

module · podcast

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence. 

Petauri Evidence mtechaccess.co.uk RSS Apple